NCT02282293View on ClinicalTrials.gov

Reducing the Burden of Malaria in HIV-Infected Pregnant Women and Their HIV-Exposed Children (PROMOTE-BC2)

PHASE3CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

December 9, 2014

Primary Completion Date

May 26, 2016

Study Completion Date

May 26, 2016

Conditions

MalariaHuman Immunodeficiency Virus

Interventions

DRUG

Monthly dihydroartemisinin-piperaquine (DP) + daily trimethoprim/sulfamethoxazole (TS)

DRUG

Monthly placebo + daily trimethoprim/sulfamethoxazole (TS)

Trial Locations (1)

Unknown

IDRC Research Clinic - Tororo District Hospital, Tororo

All Listed Sponsors

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

University of California, San Francisco

OTHER

NCT02282293 - Reducing the Burden of Malaria in HIV-Infected Pregnant Women and Their HIV-Exposed Children (PROMOTE-BC2) | Biotech Hunter | Biotech Hunter